1 year return (CAGR)
260.07%
Spyre Therapeutics Inc. Exchange (NASDAQ, USD)
SYRE
98.96
-0.20 (-0.25%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
85.49%
5 year return (CAGR)
-16.30%
10 year return (CAGR)
-7.53%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
7.05B
Price/Sales
77.85
Ent value
6.95B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 80.21 |
| Daily high | 80.52 |
| Daily low | 78.13 |
| Daily Volume | 1.27M |
| All-time high | 299.75 |
| 1y analyst estimate | 120.21 |
| Beta | 3.00 |
| EPS (TTM) | -2.11 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| SYRE | S&P500 | |
| Current price drop from All-time high | -66.99% | -1.25% |
| Highest price drop | -99.12% | -56.47% |
| Date of highest drop | 21 Jun 2023 | 9 Mar 2009 |
| Avg drop from high | -62.87% | -10.65% |
| Avg time to new high | 1324 days | 12 days |
| Max time to new high | 2647 days | 1805 days |
News
